Back to Search

JNJ

Johnson & Johnson
Data: 2026-05-18
$227.33
Price
0.27%
Change
$251.71
52W High
$149.04
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Quick Stats
May 18, 2026

64.3

AI Score

BUY

0.2

Volume Ratio

Jul 15, 2026

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

JNJ Stock Summary

Last updated

JNJ is currently trading at $227.33, positioned above its 200-day moving average of $209.52, indicating a long-term uptrend. The stock has a 52-week range of $149.04 to $251.71.

Technical Analysis: The 50-day moving average stands at $234.25, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates JNJ at 64.3/100 with a BUY recommendation.

JNJ Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

JNJ Price vs Max Options Open Interest
JNJ Max Change In Options Open Interest

JNJ Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

JNJ Daily Out of Money Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

JNJ Daily In the Money Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

JNJ Most Active Options by Volume(near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Johnson & Johnson is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

JNJ Moving Averages Analysis

Johnson & Johnson has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 18, 2026

JNJ (Johnson & Johnson) Simple Moving Averages

Moving Averages are last updated May 18, 2026

Days MA
10 225.5
20 226.35
30 230.09
50 234.25
100 230.82
200 209.52

JNJ Fundamental Analysis

P/E (Forward) 19.1205
P/E (Trailing) 26.7439
Market Cap ($) 555.6 billion
Earnings/Share ($) 8.63
Net Proft Margin (%) 0.2183
Dividend/Share ($) 5.2
EPS Estimate Current Year ($) 11.5753
EPS Estimate Next Year ($) 12.7104
WallStreet Target Price ($) 252.4167
Most Recent Quarter